Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention.
Publication
, Journal Article
Bhatt, DL; Lincoff, AM; Kereiakes, DJ; Tcheng, JE; Simoons, ML; van der Wieken, LR; Godfrey, N; Califf, RM; Topol, EJ
Published in: Am J Cardiol
November 1, 1998
Data from the 5 large randomized, double-blind, placebo-controlled trials that used glycoprotein IIb/IIIa inhibitors during percutaneous transluminal coronary angioplasty were pooled for a total of 10,691 patients. We found that the use of glycoprotein IIb/IIIa inhibitors in percutaneous coronary interventions significantly decreases the need for unplanned stenting for abrupt closure.
Duke Scholars
Published In
Am J Cardiol
DOI
ISSN
0002-9149
Publication Date
November 1, 1998
Volume
82
Issue
9
Start / End Page
1105 / A6
Location
United States
Related Subject Headings
- Treatment Outcome
- Stents
- Platelet Glycoprotein GPIIb-IIIa Complex
- Humans
- Coronary Disease
- Cardiovascular System & Hematology
- Angioplasty, Balloon, Coronary
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Bhatt, D. L., Lincoff, A. M., Kereiakes, D. J., Tcheng, J. E., Simoons, M. L., van der Wieken, L. R., … Topol, E. J. (1998). Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention. Am J Cardiol, 82(9), 1105-A6. https://doi.org/10.1016/s0002-9149(98)00565-7
Bhatt, D. L., A. M. Lincoff, D. J. Kereiakes, J. E. Tcheng, M. L. Simoons, L. R. van der Wieken, N. Godfrey, R. M. Califf, and E. J. Topol. “Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention.” Am J Cardiol 82, no. 9 (November 1, 1998): 1105-A6. https://doi.org/10.1016/s0002-9149(98)00565-7.
Bhatt DL, Lincoff AM, Kereiakes DJ, Tcheng JE, Simoons ML, van der Wieken LR, et al. Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention. Am J Cardiol. 1998 Nov 1;82(9):1105-A6.
Bhatt, D. L., et al. “Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention.” Am J Cardiol, vol. 82, no. 9, Nov. 1998, pp. 1105-A6. Pubmed, doi:10.1016/s0002-9149(98)00565-7.
Bhatt DL, Lincoff AM, Kereiakes DJ, Tcheng JE, Simoons ML, van der Wieken LR, Godfrey N, Califf RM, Topol EJ. Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention. Am J Cardiol. 1998 Nov 1;82(9):1105-A6.
Published In
Am J Cardiol
DOI
ISSN
0002-9149
Publication Date
November 1, 1998
Volume
82
Issue
9
Start / End Page
1105 / A6
Location
United States
Related Subject Headings
- Treatment Outcome
- Stents
- Platelet Glycoprotein GPIIb-IIIa Complex
- Humans
- Coronary Disease
- Cardiovascular System & Hematology
- Angioplasty, Balloon, Coronary
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology